Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4204626
Max Phase: Preclinical
Molecular Formula: C20H14Br2FN3O2S
Molecular Weight: 539.22
Molecule Type: Small molecule
Associated Items:
ID: ALA4204626
Max Phase: Preclinical
Molecular Formula: C20H14Br2FN3O2S
Molecular Weight: 539.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1c(-c2cccs2)nc2c(Br)cc(Br)cn12)c1ccc(OCCF)cc1
Standard InChI: InChI=1S/C20H14Br2FN3O2S/c21-13-10-15(22)18-24-17(16-2-1-9-29-16)19(26(18)11-13)25-20(27)12-3-5-14(6-4-12)28-8-7-23/h1-6,9-11H,7-8H2,(H,25,27)
Standard InChI Key: RGZAIYNSOCKILE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 539.22 | Molecular Weight (Monoisotopic): 536.9158 | AlogP: 6.19 | #Rotatable Bonds: 6 |
Polar Surface Area: 55.63 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 3.41 | CX LogP: 5.33 | CX LogD: 5.33 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.32 | Np Likeness Score: -1.79 |
1. Yakoub K, Jung S, Sattler C, Damerow H, Weber J, Kretzschmann A, Cankaya AS, Piel M, Rösch F, Haugaard AS, Frølund B, Schirmeister T, Lüddens H.. (2018) Structure-Function Evaluation of Imidazopyridine Derivatives Selective for δ-Subunit-Containing γ-Aminobutyric Acid Type A (GABAA) Receptors., 61 (5): [PMID:29451785] [10.1021/acs.jmedchem.7b01484] |
Source(1):